Publications

Listed below are chapters and articles about Mycoplasma pneumoniae.

Kutty PK, Jain S, Taylor TH, et al. Mycoplasma pneumoniae among children hospitalized with community-acquired pneumonia. Clin Infect Dis. 2019;68(1):5–12.
Winchell JM. Mycoplasma pneumoniae – A national public health perspective. Curr Pediatr Rev. 2013;9(4):324–33.
Waites KB, Atkinson TP. The role of mycoplasma in upper respiratory infections. Curr Infect Dis Rep. 2009;11:198–206.
Atkinson TP, Balish MF, Waites KB. Epidemiology, clinical manifestations, pathogenesis and laboratory detection of Mycoplasma pneumoniae infections. FEMS Microbiol Rev. 2008;32:956–73.
Foy HM. Infections caused by Mycoplasma pneumoniae and possible carrier state in different populations of patients. Clin Infect Dis. 1993;17:S37–46.
Foy HM, Kenny GE, McMahan R, Mansy AM, Grayston JT. Mycoplasma pneumoniae pneumonia in an urban area. Five years of surveillance. JAMA. 1970;214:1666–72.

Waites KB, Ratliff A, Crabb DM, et al. 2019. Macrolide-resistant Mycoplasma pneumoniae in the United States as determined from a national surveillance program. J Clin Microbiol. 2019;57(11):e00968–19.
Zheng X, Lee S, Selvarangan R, et al. Macrolide-resistant Mycoplasma pneumoniae, United States. Emerg Infect Dis. 2015;21(8):1470–2.
Diaz MH, Benitez AJ, Winchell JM. Investigations of Mycoplasma pneumoniae infections in the United States: Trends in molecular typing and macrolide resistance from 2006 to 2013. J Clin Microbiol. 2015;53(1):124–30.
Cardinale F, Chironna M, Chinellato I, Principi N, Esposito S. Clinical relevance of Mycoplasma pneumoniae macrolide resistance in children. J Clin Microbiol. 2013;51:723–4.
Hicks LA, Taylor Jr TH, Hunkler RD. U.S. outpatient antibiotic prescribing, 2010External. N Engl J Med. 2013;368:1461–2.
Principi N, Esposito S. Macrolide-resistant Mycoplasma pneumoniae: its role in respiratory infectionExternal. J Antimicrob Chemother. 2013;68:506–11.
Cao B, Zhao CJ, Yin YD, et al. High prevalence of macrolide resistance in Mycoplasma pneumoniae isolates from adult and adolescent patients with respiratory tract infection in ChinaExternal. Clin Infect Dis. 2010;51:189–94.
Matsubara K, Morozumi M, Okada T, et al. A comparative clinical study of macrolide-sensitive and macrolide-resistant Mycoplasma pneumoniae infections in pediatric patientsExternal. J Infect Chemother. 2009;15:380–3.
Morozumi M, Iwata S, Hasegawa K, et al. Increased macrolide resistance of Mycoplasma pneumoniae in pediatric patients with community-acquired pneumoniaExternal. Antimicrob Agents Chemother. 2008;52:348–50.
Pereyre S, Charron A, Renaudin H, Bébéar C, Bébéar CM. First report of macrolide-resistant strains and description of a novel nucleotide sequence variation in the P1 adhesin gene in Mycoplasma pneumoniae clinical strains isolated in France over 12 yearsExternal. J Clin Microbiol. 2007;45:3534–9.
Suzuki S, Yamazaki T, Narita M, et al. Clinical evaluation of macrolide-resistant Mycoplasma pneumoniaeExternal. Antimicrob Agents Chemother. 2006;50:709–12.
Matsuoka M, Narita M, Okazaki N, et al. Characterization and molecular analysis of macrolide-resistant Mycoplasma pneumoniae clinical isolates obtained in JapanExternal. Antimicrob Agents Chemother. 2004;48:4624–30.
Okazaki N, Narita M, Yamada S, et al. Characteristics of macrolide-resistant Mycoplasma pneumoniae strains isolated from patients and induced with erythromycin in vitroExternal. Microbiol Immunol. 2001;45:617–20.

Leal S, Totten A, Xiao L, et al. Evaluation of commercial molecular diagnostic methods for the detection and determination of macrolide resistance in Mycoplasma pneumoniae. J Clin Microbiol. 2020;58(6):e00242–20.
Diaz M, Winchell J. The evolution of advanced molecular diagnostics for the detection and characterization of Mycoplasma pneumoniae. Front Microbiol. 2016;7(232).
Chalker VJ, Pereyre S, Dumke R, et al for the ESCMID Study Group for Mycoplasma Infections. International Mycoplasma pneumoniae typing study: Interpretation of M. pneumoniae multilocus variable-number tandem-repeat analysis. New Microbes New Infect. 2015;7:37–40.
Diaz MH, Benitez AJ, Cross KE, et al. Molecular detection and characterization of Mycoplasma pneumoniae among patients hospitalized with community-acquired pneumonia in the United States. Open Forum Infect Dis. 2015;2(3):ofv106.
Diaz MH, Benitez AJ, Winchell JM. Investigations of Mycoplasma pneumoniae infections in the United States: Trends in molecular typing and macrolide resistance from 2006 to 2013. J Clin Microbiol. 2015;53(1):124–30.
Diaz MH, Winchell JM. Detection of Mycoplasma pneumoniae and Chlamydophila pneumoniae directly from respiratory clinical specimens using a rapid real-time polymerase chain reaction assay. Diagn Microbiol Infect Dis. 2012;73:278–80.
Petrone BL, Wolff BJ, DeLaney AA, Diaz MH, Winchell JM. Isothermal detection of Mycoplasma pneumoniae directly from respiratory clinical specimens. J Clin Microbiol. 2015;53(9):2970–6.
Waites KB. What’s new in diagnostic testing and treatment approaches for Mycoplasma pneumoniae infections in children?External Adv Exp Med Biol. 2011;719:47–57.
Thurman KA, Walter ND, Schwartz SB, et al. Comparison of laboratory diagnostic procedures for detection of Mycoplasma pneumoniae in community outbreaks. Clin Infect Dis. 2009;48:1244–9.
Atkinson TP, Balish MF, Waites KB. Epidemiology, clinical manifestations, pathogenesis and laboratory detection of Mycoplasma pneumoniae infections. FEMS Microbiol Rev. 2008;32:956–73.

Watkins LKF, Olson D, Diaz MH, et al. Epidemiology and molecular characteristics of Mycoplasma pneumoniae during an outbreak of M. pneumoniae-associated Stevens-Johnson Syndrome. Pediatr Infect Dis J. 2017;36(6):564–71.
Olson D, Watkins LKF, Demirjian A, et al. Outbreak of Mycoplasma pneumoniae-associated Stevens-Johnson Syndrome. Pediatrics. 2015;136(2):e386–94.
Waller JL, Diaz MH, Petrone B, et al. Detection and characterization of Mycoplasma pneumoniae during an outbreak of respiratory illness at a university. J Clin Microbiol. 2014;52(3):849–53.
CDC. Mycoplasma pneumoniae outbreak at a university — Georgia, 2012. MMWR. 2013;62:603–6.
Tsai V, Pritzker BB, Diaz MH, et al. Cluster of macrolide-resistant Mycoplasma pneumoniae — Illinois, 2012. J Clin Microbiol. 2013;51:3889–92.
CDC. Mycoplasma pneumoniae respiratory illness — two rural counties, West Virginia, 2011. MMWR Morb Mortal Wkly Rep. 2012;61:834–8.
Pereyre S, Renaudin H, Charron A, Bébéar C. Clonal spread of Mycoplasma pneumoniae in primary school, Bordeaux, France. Emerg Infect Dis. 2012;18:343–5.
Walter ND, Grant GB, Bandy U, et al. Community outbreak of Mycoplasma pneumoniae: school-based cluster of neurologic disease associated with household transmission of respiratory illness. J Infect Dis. 2008;198:1365–74.
Hyde TB, Gilbert M, Schwartz SB, et al. Azithromycin prophylaxis during a hospital outbreak of Mycoplasma pneumoniae pneumonia. J Infect Dis. 2001;183:907–12.
Gray GC, Callahan JD, Hawksworth AW, Fisher CA, Gaydos JC. Respiratory diseases among U.S. military personnel: countering emerging threats. Emerg Infect Dis. 1999;5:379–85.
Foy HM, Grayston JT, Kenny GE, Alexander ER, McMahan R. Epidemiology of Mycoplasma pneumoniae infection in families. JAMA. 1966;197:859–66.